AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Insurize-M 60 Tablet ER

Prescription Icon
Prescription Required

Marketer

Alcea Biotech Pvt Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Insurize-M 60 Tablet ER

Diabetol-Duo 60mg Extended Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabetol-Duo 60mg ER with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a rapid-acting glucose source (e.g., juice, candy) to counteract hypoglycemia. Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are necessary.

Primary Ingredients of Insurize-M 60 Tablet ER

No information provided. Please provide the text you wish me to rephrase.

Uses of Insurize-M 60 Tablet ER

Adult-onset diabetes

Major Benefits of Insurize-M 60 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Insurize-M 60 Tablet ER whole; avoid chewing, crushing, or breaking it. Consume this extended-release tablet with a meal.

Common Side effects of Insurize-M 60 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Insurize-M 60 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Insurize-M 60 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume with food.

How Insurize-M 60 Tablet ER works:

Insurize-M 60 ER tablets contain a dual-action formula of gliclazide and metformin, both used in diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Insurize-M 60 Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Insurize-M 60mg tablets pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Insurize-M 60mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Extended-release Insurize-M 60mg tablets require careful consideration for individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is recommended. The use of Insurize-M 60mg extended-release tablets is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Insurize-M 60 Tablet ER cautiously, potentially requiring dose modification. Consult a physician. A low starting dose is typically recommended for individuals with mild to moderate liver disease; it's not advised for those with severe hepatic dysfunction.

What if you forget to take Insurize-M 60 Tablet ER :

Should you forget a dose of Insurize-M 60 Tablet ER, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Insurize-M 60 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Insurize-M 60 Tablet ER

Insurize-M 60 Tablet ER combines gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with a healthy diet and regular physical activity. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Insurize-M 60 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Insurize-M 60 Tablet ER can cause low blood sugar (hypoglycemia), leading to symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are taken concurrently. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Insurize-M 60 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Insurize-M 60 Tablet ER and seek immediate medical attention.
Prolonged Insurize-M 60 Tablet ER use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, yearly supplemental vitamin B12 is recommended by some researchers.
Insurize-M 60 Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Insurize-M 60 Tablet ER and alcohol is unsafe. This combination may cause dangerously low blood sugar and raise the risk of lactic acidosis.
Insurize-M 60 Tablet ER combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when used with a healthy diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's unsuitable for type 1 diabetes.
Insurize-M 60 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Insurize-M 60 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Insurize-M 60 Tablet ER can cause lactic acidosis, a serious, potentially life-threatening condition characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is more likely in individuals with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Insurize-M 60 Tablet ER and seek immediate medical attention.
Prolonged use of Insurize-M 60 Tablet ER can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Insurize-M 60 Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Insurize-M 60 Tablet ER and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Insurize-M 60 Tablet ER
133
MRP 154
13% off